Published in Tissue Antigens on April 01, 1978
Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. Clin Exp Immunol (1981) 1.34
Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest (1992) 1.21
Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest (1992) 1.11
The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest (1993) 1.10
Characterization of a spontaneous disease of white leghorn chickens resembling progressive systemic sclerosis (scleroderma). J Exp Med (1981) 1.00
Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosis. Ann Rheum Dis (1986) 0.93
Retroperitoneal fibrosis and scleroderma. Postgrad Med J (1980) 0.87
HLA antigens and scleroderma. Arch Dermatol Res (1981) 0.83
Animal model of human disease. Avian scleroderma. An inherited fibrotic disease of white Leghorn chickens resembling progressive systemic sclerosis. Am J Pathol (1985) 0.80
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum (1995) 15.00
High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med (1973) 9.90
The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum (1993) 8.73
Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test. Transplantation (1968) 8.51
The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40
Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol (1978) 6.88
Significance of the positive crossmatch test in kidney transplantation. N Engl J Med (1969) 5.50
Autologous stimulation of human lymphocyte subpopulation. J Exp Med (1975) 4.80
Cytotoxins in disease. Autocytotoxins in lupus. N Engl J Med (1970) 4.40
Serotyping for homotransplantation. X. Survival of 196 grafted kidneys subsequent to typing. Transplantation (1967) 4.16
Shwartzman reaction after human renal homotransplantation. N Engl J Med (1968) 4.05
Kidney preservation for transportation. Initial perfusion and 30 hours' ice storage. Lancet (1969) 3.67
Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist. Arthritis Rheum (2004) 3.46
Effect of blood transfusions on subsequent kidney transplants. Transplant Proc (1973) 3.42
Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. N Engl J Med (1993) 3.36
Nomenclature for factors of the HLA system, 2010. Tissue Antigens (2010) 3.22
Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group. Arch Intern Med (1999) 3.10
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. Arthritis Rheum (2004) 3.00
Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00
Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest (1974) 2.96
Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med (1978) 2.52
Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation. Lancet (1995) 2.50
Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med (1998) 2.48
Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med (1990) 2.40
Thoracic duct drainage before and after cadaveric kidney transplantation. Surg Gynecol Obstet (1979) 2.33
SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS. Ann N Y Acad Sci (1966) 2.25
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival. Transplantation (1995) 2.13
Influence of test technique on sensitization status of patients on the kidney transplant waiting list. Am J Transplant (2013) 2.12
Equitable allocation of HLA-compatible kidneys for local pools and minorities. N Engl J Med (1994) 2.12
Reactivity of lymphocytes from normal persons on cultured tumor cells. Cancer Res (1973) 2.11
Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med (1992) 2.09
Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06
Characterization of sialosylated Lewisx as a new tumor-associated antigen. Cancer Res (1984) 2.02
The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol (1998) 1.97
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum (1998) 1.93
[Immunological aspects of kidney transplantation in Switzerland 1981-1992. Swiss Transplant Work Group Kidney Transplantation]. Schweiz Med Wochenschr (1995) 1.91
Nomenclature for factors of the HLA system, 2002. Tissue Antigens (2002) 1.89
Analysis of HL-A incompatibility in human renal transplants. Tissue Antigens (1971) 1.89
A semimicro mixed leukocyte culture test. Transplantation (1971) 1.85
Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations. Arthritis Rheum (1978) 1.83
Juvenile myoclonic epilepsy (JME) may be linked to the BF and HLA loci on human chromosome 6. Am J Med Genet (1988) 1.82
Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study. Arthritis Rheum (1989) 1.80
Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F 1 hybrids. J Natl Cancer Inst (1973) 1.79
Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78
Clinical and serological comparison of 17 chronic progressive systemic sclerosis (PSS) and 17 CREST syndrome patients matched for sex, age, and disease duration. Ann Rheum Dis (1984) 1.76
Minimally important difference in diffuse systemic sclerosis: results from the D-penicillamine study. Ann Rheum Dis (2006) 1.70
Enhancement of human kidney allografts by cold B-lymphocyte cytotoxins. Lancet (1978) 1.70
Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med (1983) 1.70
DNA damage and repair in female C57BL/10 mice of different ages injected with the carcinogen benzo[a]pyrene-trans-7,8-diol. Mutat Res (1989) 1.68
Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Arthritis Rheum (2001) 1.68
Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. N Engl J Med (1977) 1.67
Multiple sclerosis: association with HL-A3. Tissue Antigens (1972) 1.65
Successful renal allografts across a positive cross-match for donor B-lymphocyte alloantigens. Lancet (1976) 1.63
Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med (1972) 1.63
Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2000) 1.62
Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis). Ann Intern Med (1993) 1.61
Cross reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation (1973) 1.60
Thoracic duct fistula and renal transplantation. Ann Surg (1979) 1.60
Influence of race on kidney transplant survival. Transplant Proc (1977) 1.58
The health assessment questionnaire (HAQ) is strongly predictive of good outcome in early diffuse scleroderma: results from an analysis of two randomized controlled trials in early diffuse scleroderma. Rheumatology (Oxford) (2003) 1.58
Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med (1974) 1.58
Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogeneic marrow. Crucial role of histocompatiility matching. N Engl J Med (1969) 1.58
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58
Nomenclature for factors of the HLA system, 2004. Tissue Antigens (2005) 1.57
HLA matching and cadaver kidney transplant survival in North America: influence of center variation and presensitization. Transplantation (1977) 1.56
Empirical validation of the Essen-Möller probability of paternity. Am J Hum Genet (1986) 1.56
Follow-up study of juvenile chronic polyarthritis with particular reference to histocompatibility antigen W. 27. Ann Rheum Dis (1974) 1.55
Anti-HLA antibodies after solid organ transplantation. Transplantation (2000) 1.54
Impaired in-vitro lymphocyte responses in patients with elevated pentachlorophenol (PCP) blood levels. Arch Environ Health (1995) 1.52
Impact of IgG3 subclass and C1q-fixing donor-specific HLA alloantibodies on rejection and survival in liver transplantation. Am J Transplant (2015) 1.50
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind study. Ann Intern Med (1994) 1.50
HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. N Engl J Med (1976) 1.49
Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum (1984) 1.46
HLA and the inheritance of multiple sclerosis: linkage analysis of 72 pedigrees. Am J Hum Genet (1980) 1.46
Cytotoxins in disease. 3. Antibodies against lymphocytes produced by vaccination. Transplantation (1970) 1.46
HLA genotypic study of insulin-dependent diabetes the excess of DR3/DR4 heterozygotes allows rejection of the recessive hypothesis. Diabetes (1983) 1.45
Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg (1980) 1.45
Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies. Am J Transplant (2013) 1.44